Skip to content
Open access

Discovery of a Cell-Permeable Gi-Signaling Inhibitor

Aug 2026 · bioRxiv · 0 citations · 16 references
Biology

TL;DR

N-hydroxyapiosporamide (NHAP) is established as a first-in-class Gi-selective inhibitor, providing a cell-permeable chemical scaffold for the optimization of next-generation agents to control Gi-signaling in cell-based systems and, ultimately, to target Gαi1-driven pathologies.

Read PDF

Similar papers

Open access Sep 2026

GPCR antagonism via rewiring of receptor trafficking and degradation

A novel strategy for functional GPCR antagonism via bispecific antibody-mediated endocytosis and lysosomal degradation is reported via bispecific antibody-mediated endocytosis and lysosomal degradation, establishing induced endocytosis and rewiring protein trafficking as a new paradigm for therapeutic GPCR modulation.

Kaitlin Rhee, L. Shue, Akimasa Adachi et al. · 1 citation
Sep 2026

Development of Isoform-Selective GRP78 Inhibitors from a Direct-to-Biology Strategy

The development of isoform-selective HSP70 inhibitors remains challenging due to the high conservation of this chaperone family. Continuing our efforts to target the peptide-binding pocket within the substrate-binding domain (SBD) of GRP78 (BiP/HSPA5), we identified compound 12 using a Direct-to-Biology (D2B) strateg...

Xiao-Yi Zhu, Qiu Li, Ke Wang et al. · 0 citations
Open access Aug 2026

Structural basis of endogenous lipid recognition and G protein selectivity in GPR119

G protein-coupled receptors (GPCRs) often engage multiple intracellular transducers, yet the structural basis by which endogenous ligands influence G protein selectivity remains poorly understood. GPR119 is a lipid-activated receptor expressed in pancreatic β-cells and enteroendocrine L-cells, where it regulates glucos...

Donggyun Kim, Mohsen Ranjbar, Aleksey Raskovalov et al. · 0 citations
Review Sep 2026

Bias from within: intracellular allosterism and the ICL2 hub.

Targeting the orthosteric site of G protein-coupled receptors (GPCRs) has long dominated drug discovery, but intracellular allosteric modulators (AMs) provide new avenues to enhance selectivity and fine-tune signaling. Recent structural advances have illuminated intracellular allosteric pockets that act as conformation...

Yang Zhou, Alan Long, Joshua D. Gross et al. · 0 citations
Open access Sep 2026

Pharmacological modulation of GPR84 revealed by dual states structures and immune functional assays

Cryo-electron microscopy structures of GPR84 in both active and inactive states revealed how different ligands interact with GPR84, influencing its signaling pathways, and provided a structural basis for designing selective modulators of GPR84, which could lead to new therapeutic strategies for diseases involving immun...

Myung Kyung Choi, D. Park, Pankyung Kim et al. · 0 citations
Open access Sep 2026

Design and structural basis of selective nonsteroidal inhibitors of aster cholesterol trafficking

Significance Cholesterol transport by Aster proteins from the plasma membrane (PM) to the endoplasmic reticulum is important for cholesterol homeostasis. We identify nonsteroidal Aster inhibitors with improved specificity and reduced toxicity compared to sterol-based inhibitors. YKJ-124, a low-toxicity Aster-A preferri...

Hyunsoo Kim, B. Romartínez-Alonso, Xu Xiao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.